این سایت در حال حاضر پشتیبانی نمی شود و امکان دارد داده های نشریات بروز نباشند
صفحه اصلی
درباره پایگاه
فهرست سامانه ها
الزامات سامانه ها
فهرست سازمانی
تماس با ما
JCR 2016
جستجوی مقالات
جمعه 12 دی 1404
Iranian Journal of Immunology
، جلد ۲۱، شماره ۱، صفحات ۵۳-۶۴
عنوان فارسی
چکیده فارسی مقاله
کلیدواژههای فارسی مقاله
عنوان انگلیسی
Intervention with ICOSL Antibodies Alleviates Inflammatory Infiltrations in Mice with Neutrophilic Asthma
چکیده انگلیسی مقاله
Background: Neutrophilic asthma is characterized by the predominant infiltration of neutrophils in airway inflammation.
Objective: To explore the therapeutic potential of an antibody against the inducible T cell co-stimulator ligand (ICOSL) in a mouse model of neutrophilic asthma.
Methods: Female BALB/c mice were randomly assigned to different groups. They were then injected with ovalbumin (OVA)/lipopolysaccharides (LPS) to induce neutrophilic asthma. The mice were then treated with either anti-ICOSL (the I group), control IgG (the G group), or no treatment (the N group). Additionally, a control group of mice received vehicle PBS and was labeled as the C group (n=6 per group). One day after the last allergen exposure, cytokine levels were measured in plasma and bronchoalveolar lavage fluid (BALF) using ELISA. After analyzing and categorizing BALF cells, the lung tissues were examined histologically and immunohistochemically.
Results: Administering anti-ICOSL resulted in a significant decrease in the total number of inflammatory infiltrates and neutrophils found in BALF. Moreover, it led to a decrease in the levels of interleukin (IL)-6, IL-13, and IL-17 in both BALF and plasma. Additionally, there was an increase in IFN-γ levels in the BALF of asthmatic mice (p<0.05 for all). Treatment with anti-ICOSL also reduced lung interstitial inflammation, mucus secretion, and ICOSL expression in asthmatic mice.
Conclusion: The treatment of anti-ICOSL effectively improved lung interstitial inflammation and mucus secretion in mice with neutrophilic asthma by restoring the balance of Th1/Th2/Th17 responses. These findings indicate that blocking the ICOS/ICOSL signaling could be an effective way to manage neutrophilic asthma.
کلیدواژههای انگلیسی مقاله
Asthma, Inducible T Cell Co-Stimulator Ligand, Neutrophils, Pathology
نویسندگان مقاله
Heting Dong |
Department of Respiratory Medicine, Children’s Hospital of Soochow University, Suzhou 215003, China.
Yinying Ren |
Department of Respiratory Medicine, Children’s Hospital of Soochow University, Suzhou 215003, China.
Yiyi Song |
Suzhou Medical College, Soochow University, Suzhou 215003, China.
Wei Ji |
Department of Respiratory Medicine, Children’s Hospital of Soochow University, Suzhou 215003, China.
Yongdong Yan |
Department of Respiratory Medicine, Children’s Hospital of Soochow University, Suzhou 215003, China.
Canhong Zhu |
Department of Respiratory Medicine, Children’s Hospital of Soochow University, Suzhou 215003, China.
Li Huang |
Department of Respiratory Medicine, Children’s Hospital of Soochow University, Suzhou 215003, China.
Meijuan Wang |
Department of Respiratory Medicine, Children’s Hospital of Soochow University, Suzhou 215003, China.
Wenjing Gu |
Department of Respiratory Medicine, Children’s Hospital of Soochow University, Suzhou 215003, China.
Xinxing Zhang |
Department of Respiratory Medicine, Children’s Hospital of Soochow University, Suzhou 215003, China.
Huiming Sun |
Department of Respiratory Medicine, Children’s Hospital of Soochow University, Suzhou 215003, China.
Chuangli Hao |
Department of Respiratory Medicine, Children’s Hospital of Soochow University, Suzhou 215003, China.
Zhengrong Chen |
Department of Respiratory Medicine, Children’s Hospital of Soochow University, Suzhou 215003, China.
نشانی اینترنتی
https://iji.sums.ac.ir/article_49834_fa0e487e0f77f0118df12defe3abaa74.pdf
فایل مقاله
فایلی برای مقاله ذخیره نشده است
کد مقاله (doi)
زبان مقاله منتشر شده
en
موضوعات مقاله منتشر شده
نوع مقاله منتشر شده
برگشت به:
صفحه اول پایگاه
|
نسخه مرتبط
|
نشریه مرتبط
|
فهرست نشریات